News & Press Releases

News and Upcoming Events

Press Releases:

June 1, 2020

Kleo Pharmaceuticals to Present Corporate Overview and Pipeline Update at Jefferies Virtual Healthcare Conference

May 21, 2020

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration to Rapidly Develop Allogeneic NK Cell Combination Therapies for COVID-19 and Multiple Myeloma

May 15, 2020

Kleo Pharmaceuticals to Present Preclinical Data Highlighting the Synergistic Potential of Kleo Asset KP1237 and Autologous NK Cells in the Treatment of Multiple Myeloma at the 2020 American Society of Clinical Oncology Virtual Meeting

April 7, 2020

BIOTUESDAYS- Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

April 2, 2020

New Haven Biotech Company Joins Race To Develop Coronavirus Drug

March 31, 2020

Kleo Pharmaceuticals Enters into Research Collaboration with Green Cross LabCell (GCLC) To Rapidly Develop COVID-19-Targeting Allogeneic NK Cell Combination Therapy

February 14, 2020

Kleo Pharmaceuticals Elects CEO Doug Manion, MD, FCRP (C), New Chairman of the Board

February 6, 2020

Kleo Pharmaceuticals Receives IND Authorization to Proceed from FDA for its Multiple Myeloma Therapeutic

January 21, 2020

Platform Technologies Emerge in Biopharma

December 18, 2019

Kleo Pharmaceuticals to Present at Biotech Showcase 2020

LOAD MORE

Podcasts:

November 21, 2019

KLEO Pharmaceuticals Developing Cancer Therapeutics


November 21, 2019

Kleo Pharmaceuticals – Immuno-Oncology Drugs


November 21, 2019

A Doctor’s Personal Journey From Engineer to Pharmaceutical Development


Upcoming Events:

October 2020
No event found!

Archive by Year